| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accelerating the path towards a cure for Parkinson's disease
|
The Lancet Neurology,
|
|
|
24 |
8 |
p. 625
|
artikel
|
| 2 |
Acute-onset axonal neuropathy following infection in children with biallelic RCC1 variants: a case series
|
Harkness, J Robert
|
|
|
24 |
8 |
p. 667-680
|
artikel
|
| 3 |
Avindra Nath: in pursuit of pandemics
|
Thorley, Jennifer
|
|
|
24 |
8 |
p. 640
|
artikel
|
| 4 |
Bruton's tyrosine kinase inhibitors for multiple sclerosis
|
Airas, Laura
|
|
|
24 |
8 |
p. 627-628
|
artikel
|
| 5 |
Fiona Baumer
|
|
|
|
24 |
8 |
p. 641
|
artikel
|
| 6 |
Focused ultrasound therapy for movement disorders
|
Martínez-Fernández, Raúl
|
|
|
24 |
8 |
p. 698-712
|
artikel
|
| 7 |
Functional or hysterical?
|
Weatherall, Mark
|
|
|
24 |
8 |
p. 641
|
artikel
|
| 8 |
Gait training after stroke: are physiotherapists overcautious?
|
Kwakkel, Gert
|
|
|
24 |
8 |
p. 626-627
|
artikel
|
| 9 |
Interpreting the evidence on gantenerumab for dominantly inherited Alzheimer's disease
|
Walsh, Sebastian
|
|
|
24 |
8 |
p. 634
|
artikel
|
| 10 |
Interpreting the evidence on gantenerumab for dominantly inherited Alzheimer's disease
|
Cheng, Yangfan
|
|
|
24 |
8 |
p. 634
|
artikel
|
| 11 |
Interpreting the evidence on gantenerumab for dominantly inherited Alzheimer's disease – Authors' reply
|
Li, Yan
|
|
|
24 |
8 |
p. 635-636
|
artikel
|
| 12 |
Over a decade of MR-guided focused ultrasound
|
Fasano, Alfonso
|
|
|
24 |
8 |
p. 630-632
|
artikel
|
| 13 |
Rethinking neuromodulation in stroke: lessons from TRANSPORT2
|
da Silva Arêas, Fernando Zanela
|
|
|
24 |
8 |
p. 636
|
artikel
|
| 14 |
Rethinking neuromodulation in stroke: lessons from TRANSPORT2
|
Perrey, Stéphane
|
|
|
24 |
8 |
p. 636-637
|
artikel
|
| 15 |
Rethinking neuromodulation in stroke: lessons from TRANSPORT2 – Authors' reply
|
Feng, Wuwei
|
|
|
24 |
8 |
p. 637-638
|
artikel
|
| 16 |
Safety and effectiveness of the Walk ‘n Watch structured, progressive exercise protocol delivered by physical therapists for inpatient stroke rehabilitation in Canada: a phase 3, multisite, pragmatic, stepped-wedge, cluster-randomised controlled trial
|
Peters, Sue
|
|
|
24 |
8 |
p. 643-655
|
artikel
|
| 17 |
Safety and efficacy of fenebrutinib in relapsing multiple sclerosis (FENopta): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial and open-label extension study
|
Bar-Or, Amit
|
|
|
24 |
8 |
p. 656-666
|
artikel
|
| 18 |
Superheroes come in all shapes and sizes
|
Morgan, Jules
|
|
|
24 |
8 |
p. 642
|
artikel
|
| 19 |
α-synuclein biomarker assays: bridging research and patient care
|
Agin-Liebes, Julian
|
|
|
24 |
8 |
p. 681-697
|
artikel
|
| 20 |
Updates to the ILAE seizure classification
|
Jette, Nathalie
|
|
|
24 |
8 |
p. 632-633
|
artikel
|
| 21 |
Video games for people with neurological disorders
|
Brigo, Francesco
|
|
|
24 |
8 |
p. 638-639
|
artikel
|
| 22 |
When children diagnosed with Guillain-Barré syndrome do not recover
|
de Wit, Marie-Claire Y
|
|
|
24 |
8 |
p. 629-630
|
artikel
|
Tijdschrift beschrijving